Supply Agreements in the Biotechnology Industry

409 Contracts & Agreements

Browse by Company

89bio, Inc. (1 contract)
ACADIA PHARMACEUTICALS INC (4)
ACHIEVE LIFE SCIENCES, INC. (2)
Acorda Therapeutics (5)
Adamas Pharmaceuticals Inc (3)
Adhera Therapeutics, Inc. (2)
ADMA BIOLOGICS, INC. (2)
Advaxis, Inc. (1)
AGENUS INC (2)
Aimmune Therapeutics, Inc. (2)
Akebia Therapeutics, Inc. (13)
ALBIREO PHARMA, INC. (4)
Alexion Pharmaceuticals (1)
Alkermes plc. (6)
Alliqua BioMedical, Inc. (2)
Alpha Healthcare Acquisition Corp. (3)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (9)
Amgen Inc. (4)
AMICUS THERAPEUTICS, INC. (2)
Anika Therapeutics (1)
Apellis Pharmaceuticals, Inc. (1)
Aprea Therapeutics, Inc. (1)
Aptevo Therapeutics Inc. (1)
Aravive, Inc. (5)
Arcturus Therapeutics Holdings Inc. (1)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (2)
ARENA PHARMACEUTICALS INC (2)
Athenex, Inc. (2)
ATOSSA GENETICS INC (1)
Aurinia Pharmaceuticals Inc. (2)
BELLICUM PHARMACEUTICALS, INC (1)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOTIME INC (2)
BioXcel Therapeutics, Inc. (1)
bluebird bio, Inc. (6)
Bolt Biotherapeutics, Inc. (2)
Bone Biologics Corp (1)
Cabaletta Bio, Inc. (2)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
CATALYST BIOSCIENCES, INC. (2)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Century Therapeutics, Inc. (1)
Chelsea Worldwide Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (2)
Conatus Pharmaceuticals Inc. (1)
CTI BIOPHARMA CORP (1)
Cyclacel Pharmaceuticals, Inc. (1)
CytoDyn Inc. (11)
CYTRX CORP (1)
Deciphera Pharmaceuticals, Inc. (2)
Dermavant Sciences Ltd (2)
DiaMedica Therapeutics Inc. (1)
DYNAVAX TECHNOLOGIES CORP (12)
Eagle Pharmaceuticals, Inc. (3)
Edge Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (1)
Emergent BioSolutions Inc. (1)
Equillium, Inc. (2)
Evelo Biosciences, Inc. (1)
Exelixis (6)
FIBROGEN INC (5)
Flex Pharma, Inc. (1)
Flexion Therapeutics Inc (8)
FS Development Corp. (2)
GALECTIN THERAPEUTICS INC (1)
Gemphire Therapeutics Inc. (2)
GENEREX BIOTECHNOLOGY CORP (1)
Gilead Sciences (8)
Grail, Inc. (2)
HEMISPHERX BIOPHARMA INC (3)
HISTOGENICS CORP (3)
Homology Medicines, Inc. (1)
HUMANIGEN, INC (1)
IMMUCELL CORP (1)
IMMUNOGEN INC (1)
INSMED Inc (2)
Inspyr Therapeutics, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (4)
IRONWOOD PHARMACEUTICALS INC (3)
Isoray, Inc. (9)
Kadmon Holdings, Inc. (2)
Kindred Biosciences, Inc. (3)
Kiniksa Pharmaceuticals, Ltd. (1)
LEXICON PHARMACEUTICALS, INC. (2)
Ligand Pharmaceuticals Incorporated (11)
MACROGENICS INC (2)
MANNKIND CORP (15)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (1)
MEI Pharma, Inc. (1)
Minerva Neurosciences, Inc. (1)
Myovant Sciences Ltd. (5)
NantKwest, Inc. (1)
Natera, Inc. (7)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
Neurotrope, Inc. (1)
NOVAVAX INC (5)
OncBioMune Pharmaceuticals, Inc (1)
ONCOSEC MEDICAL Inc (1)
OPGEN INC (1)
Ophthotech Corp. (1)
PALATIN TECHNOLOGIES INC (3)
PDL BIOPHARMA, INC. (2)
PhaseBio Pharmaceuticals Inc (1)
PORTOLA PHARMACEUTICALS INC (2)
Progenics Pharmaceuticals, Inc. (1)
PROGENITY, INC. (2)
Protalix BioTherapeutics, Inc. (2)
PUMA BIOTECHNOLOGY, INC. (1)
Radius Health, Inc. (6)
Regeneron Pharmaceuticals (7)
RenovoRx, Inc. (1)
Retrophin, Inc. (3)
RIGEL PHARMACEUTICALS INC (2)
RITTER PHARMACEUTICALS INC (2)
Sage Therapeutics, Inc. (3)
Sana Biotechnology, Inc. (2)
Sarepta Therapeutics, Inc. (1)
Savara Inc (4)
SEATTLE GENETICS INC (14)
Seres Therapeutics, Inc. (3)
SOLIGENIX, INC. (1)
SOPHIRIS BIO INC. (1)
Spectrum Pharmaceuticals, Inc. (9)
SPHERIX INC (1)
SYNLOGIC, INC. (1)
T2 Biosystems, Inc. (6)
TENAX THERAPEUTICS, INC. (1)
Translate Bio, Inc. (1)
TREVENA INC (1)
Twist Bioscience Corp (2)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (4)
Unicycive Therapeutics, Inc. (2)
United Therapeutics Corp (3)
UroGen Pharma Ltd. (3)
Vaxart, Inc. (1)
Vaxcyte, Inc. (2)
VBI Vaccines Inc (1)
Vericel Corp (4)
VICAL INC (5)
Viela Bio, Inc. (2)
VITRO DIAGNOSTICS INC (2)
WINDTREE THERAPEUTICS INC (2)
Xencor Inc (2)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Supply Agreement, dated October 2, 2015, by and between the Registrant (as successor to Cantex Pharmaceuticals, Inc.) and Scientific Protein Laboratories LLC

Supply Agreements

CHIMERIX INC

Biotechnology

2019

Third Amendment to Supply Agreement, dated April 11, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc

Supply Agreements

MANNKIND CORP

Biotechnology

2024

Second Amendment to Supply Agreement, dated November 9, 2016, by and between MannKind and Amphastar Pharmaceuticals, Inc

Supply Agreements

MANNKIND CORP

Biotechnology

2024

Amendment #1 to Supply Agreement, dated October 15, 2024, by and between the Company and STA Pharmaceutical Hong Kong Limited

Supply Agreements

Akebia Therapeutics, Inc.

Biotechnology

2024

Supply Agreement with Kissei Pharmaceutical Co., Ltd., dated September 3, 2024

Supply Agreements

RIGEL PHARMACEUTICALS INC

Biotechnology

2024

Commercial Supply Agreement, dated October 25, 2024, by and among Ardelyx, Inc., Hovione Farmaciência, S.A. and Hovione, LLC

Supply Agreements

ARDELYX, INC.

Biotechnology

2024

Amendment No. 6 to Clinical and Commercial Supply Agreement Viral Vector Product by and between the Registrant and SAFC Carlsbad, Inc

Supply Agreements

bluebird bio, Inc.

Biotechnology

2024

First Amendment to Manufacturing and Supply Agreement dated June 25, 2024 by and between Unicycive Therapeutics, Inc. and Shilpa Medicare Ltd

Supply Agreements

Unicycive Therapeutics, Inc.

Biotechnology

2024

Manufacturing and Supply Agreement dated as of October 31, 2020 by and between Unicycive Therapeutics, Inc. and Shilpa Medicare Ltd

Supply Agreements

Unicycive Therapeutics, Inc.

Biotechnology

2024

Commercial Supply Agreement, dated August 7, 2024 and effective as of July 23, 2024, by and between the Company and Catalent

Supply Agreements

ARDELYX, INC.

Biotechnology

2024

Fourth Amendment to the Licence and Supply Agreement, dated as of June 24, 2024, between the Registrant and Oxford Biomedica (UK) Limited

Supply Agreements

Cabaletta Bio, Inc.

Biotechnology

2024

Amendment #2 to Supply Agreement, dated as of April 15, 2024, by and between the Company and STA Pharmaceutical Hong Kong Limited

Supply Agreements

Akebia Therapeutics, Inc.

Biotechnology

2024

First Amendment to the Supply and Manufacturing Services Agreement

Supply Agreements

AMICUS THERAPEUTICS, INC.

Biotechnology

2024

Amendment No. 1, dated July 11, 2024, to Commercial Supply Agreement, between ARx, LLC and BioXcel Therapeutics, Inc., dated April 1, 2022

Supply Agreements

BioXcel Therapeutics, Inc.

Biotechnology

2024

Fourth Amendment to the Amended and Restated Supply and Commercialization Agreement, dated June 24, 2024, by and between Illumina, Inc. and GRAIL, Inc

Supply Agreements

Grail, Inc.

Biotechnology

2024

Supply Agreement, dated September 15, 2015, by and between the Registrant and GenIbet BioPharmaceuticals, SA, as amended

Supply Agreements

Seres Therapeutics, Inc.

Biotechnology

2024

Amended and Restated Exclusive Supply Agreement, dated April 25, 2024, between Clene Nanomedicine, Inc. and 4Life Research, LLC

Supply Agreements

Chelsea Worldwide Inc.

Biotechnology

2024

Master Services Agreement for Product Supply between Marker Therapeutics, Inc. and Cell Ready LLC dated February 22, 2024

Supply Agreements

Marker Therapeutics, Inc.

Biotechnology

2024

Amendment 2 to Manufacturing & Supply Agreement, dated as of December 28, 2023 by and between UroGen Pharma Ltd. and Cenexi-Laboratoires Thissen s.a

Supply Agreements

UroGen Pharma Ltd.

Biotechnology

2024

Amendment No. 2 to the Manufacture and Supply Agreement, dated December 13, 2023 entered into by and between Savara ApS GEMABIOTECH SAU

Supply Agreements

Savara Inc

Biotechnology

2024

Supply Agreement, dated September 15, 2015, by and between Registrant and GenIbet BioPharmaceuticals, SA, as amended

Supply Agreements

Seres Therapeutics, Inc.

Biotechnology

2024

Eighth Amendment to Supply Agreement, dated December 31, 2023, by and between the Registrant and Illumina, Inc

Supply Agreements

Natera, Inc.

Biotechnology

2024

Commercial Supply Agreement, dated March 1, 2023, by and between the Registrant and CoreRx Inc., as amended by Amendment No. 1, dated August 1, 2023

Supply Agreements

ACADIA PHARMACEUTICALS INC

Biotechnology

2024

Commercial Supply Agreement, dated December 15, 2021, by and between the Registrant and F.I.S. Fabbrica Italiana Sintetici S.p.A

Supply Agreements

ACADIA PHARMACEUTICALS INC

Biotechnology

2024

Master Commercial Supply Agreement, dated November 16, 2022, by and between the Registrant and Corden Pharma Bergamo S.p.A

Supply Agreements

ACADIA PHARMACEUTICALS INC

Biotechnology

2024

Commercial Manufacturing and Supply Agreement by and between the Registrant and Lonza Ltd., dated October 13, 2023

Supply Agreements

Vaxcyte, Inc.

Biotechnology

2024

Commercial Supply Agreement, dated June 19, 2023, between Ultragenyx Pharmaceutical Inc. and IOI Oleo GmbH

Supply Agreements

Ultragenyx Pharmaceutical Inc.

Biotechnology

2024

Supply Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora

Supply Agreements

VITRO DIAGNOSTICS INC

Biotechnology

2024

Supply Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences

Supply Agreements

VBI Vaccines Inc

Biotechnology

2023

Supply Agreement, effective as of September 7, 2023, by and between Company and Nitto Denko Avecia Inc

Supply Agreements

DYNAVAX TECHNOLOGIES CORP

Biotechnology

2023

Supply Agreement, dated September 26, 2003, by and between Acorda Therapeutics, Inc. and Elan Corporation, plc

Supply Agreements

Alkermes plc.

Biotechnology

2023

Manufacturing and Supply Agreement - Amendment No. 2, dated May 19, 2023, by and between the Registrant and Isotopia Molecular Imaging Ltd

Supply Agreements

UroGen Pharma Ltd.

Biotechnology

2023

Clinical Supply Agreement, dated May 22, 2017, by and between Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018)

Supply Agreements

Equillium, Inc.

Biotechnology

2023

Supply and Manufacturing Services Agreement, dated as of March 31, 2023, by and among the Company, WuXi Biologics (Hong Kong) Limited, WuXi Biologics Ireland Limited and WuXi...

Supply Agreements

AMICUS THERAPEUTICS, INC.

Biotechnology

2023

Amendment No. 3 to Supply Agreement, by and between the Registrant and CyDex Pharmaceuticals, Inc., dated September 25, 2015

Supply Agreements

Sage Therapeutics, Inc.

Biotechnology

2023

Supply Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated December 13, 2012, as amended August 21, 2013 and April 30, 2014

Supply Agreements

Sage Therapeutics, Inc.

Biotechnology

2023

Amendment No. 3 to Supply Agreement, dated effective as of April 26, 2023, by and between Company and Biological E. Limited

Supply Agreements

DYNAVAX TECHNOLOGIES CORP

Biotechnology

2023

Amendment to the Agreement for the Supply of Manufactured Products, dated May 15, 2023, between Intercept Pharma Europe Ltd. and Amdipharm Ltd

Supply Agreements

INTERCEPT PHARMACEUTICALS, INC.

Biotechnology

2023

Commercial Manufacturing and Supply Agreement, dated March 14, 2023, between the Registrant and Agilent Technologies, Inc

Supply Agreements

Ophthotech Corp.

Biotechnology

2023

Second Amendment to Supply Agreement, dated as of January 1, 2022, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd

Supply Agreements

Spectrum Pharmaceuticals, Inc.

Biotechnology

2023

First Amendment to Supply Agreement, dated as of December 6, 2019, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd

Supply Agreements

Spectrum Pharmaceuticals, Inc.

Biotechnology

2023

Category

Industry

Companies

Contracts

Supply Agreements in the Biotechnology Industry